Advertisement

Nonsurgical Management of Vesicourethral Dysfunction

  • J. Keith Light

Abstract

The conservative or nonsurgical treatment of voiding dysfunction has improved significantly, due predominantly to an improved understanding of the basic neurophysiologic mechanisms regulating the function of the bladder, prostate, and urethra. An example is the recent surge in nonsurgical treatment of benign prostatic hyperplasia. Due to the expected increase in the aging population, together with the current cost of traditional surgery, it is expected that knowledge regarding the medical treatment of benign prostatic hyperplasia will rapidly advance over the next few years. As such, this chapter has been expanded to include current knowledge regarding medical treatment of this condition.

Keywords

Benign Prostatic Hyperplasia Bladder Neck Lower Urinary Tract Detrusor Contraction Prostatic Capsule 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Brindley GS, Polkey CE, Rushton DN: Sacral anterior root stimulators for bladder control in paraplegic and quadriplegic patients. J Neurol Neurosurg Psychiatry 45: 952, 1983.Google Scholar
  2. 2.
    Juenemann KP, Lue TF, Schmidt RA, Tanagho EA: The clinical significance of sacral and pudendal nerve anatomy. J Urol 139: 74–80, 1988.PubMedGoogle Scholar
  3. 3.
    Ambache N, Zar MA: Noncholinergic transmission by post-ganglionic motor neurons in the mammalian bladder. J Physiol (Lond) 210: 761, 1970.Google Scholar
  4. 4.
    Cowan WD, Daniel EE: Human female bladder and its noncholinergic contractile function. Can J Physiol Pharmacol 61: 1236, 1983.PubMedCrossRefGoogle Scholar
  5. 5.
    Burnstock G: Purinergic nerves. Pharmacol Rev 24: 509, 1972.PubMedGoogle Scholar
  6. 6.
    Baumgarten JG, Holstein AF, Owman CH: Auerbach’s plexus of mammals of man: electron microscopic identification of three different types of neuronal processes in mesenteric ganglia of the large intestine from rhesus monkey, guinea-pigs and man. Z Zellforschung Mikroskop Anat 106: 376, 1970.CrossRefGoogle Scholar
  7. 7.
    Sjogren C, Andersson K-E, Husted S, Mattiasson A, Moller-Madsen B: Atropine resistance of transmurally stimulated isolated human bladder muscle. J Urol 128: 1368, 1982.PubMedGoogle Scholar
  8. 8.
    DeGroat WC, Booth AM, Kriev J: Interaction between sacral parasympathetic and lumbar sympathetic inputs to pelvic ganglia. In: CM Brooks, K Koizani, A Sato, eds, Integrative Functions of the Autonomic Nervous System. University of Tokyo Press, Tokyo, pp 234-247, 19.Google Scholar
  9. 9.
    Sundin T, Dahlstrom A, Norlen L, Svedmyr N: The sympa-thetic innervation and adrenoreceptor function of the human lower urinary tract in the normal state and after parasympathetic denervation. Invest Urol 14: 322–328, 1977.PubMedGoogle Scholar
  10. 10.
    Perlberg S, Caine M: Adrenergic response of bladder muscle in prostatic obstruction. Urology 20: 524–527, 1982.PubMedCrossRefGoogle Scholar
  11. 11.
    Vodusek DB, Light JK: The motor nerve supply of the external urethral sphincter muscles: An electrophysiologic study. Neurourol Urodynam 2: 193–200, 1983.CrossRefGoogle Scholar
  12. 12.
    Gosling JA: The structure of the bladder and urethra in relation to function. Urol Clin North Am 6: 31–38, 1979.PubMedGoogle Scholar
  13. 13.
    Gosling JA, Dixon JS, Critchley HOD, Thompson SA: A comparative study of the human external sphincter and periurethral levator ani muscles. Br J Urol 53: 35–41, 1981.PubMedCrossRefGoogle Scholar
  14. 14.
    Benson GS, Sarshik SA, Raezer D, Wein AJ: Bladder muscle contractility. Comparative effects of and mechanisms of actions of atropine, propantheline, flavoxate, and imipramine. Urology 9: 31–35, 1977.PubMedCrossRefGoogle Scholar
  15. 15.
    Briggs RS, Castleden CM, Asher MJ: The effect of flavoxate on uninhibited detrusor contractions and urinary incontinence in the elderly. J Urol 123: 665–666, 1980.PubMedGoogle Scholar
  16. 16.
    McGuire EJ, Savastano JA: Effect of alpha-adrenergic blockade and anticholinergic agents on the decentralized primate bladder. Neurourol Urodynam 4: 139–142, 1985.CrossRefGoogle Scholar
  17. 17.
    Forman A, Andersson K-E, Hendriksson L, Rud T, Ulmsten U: Effect of nifedipine on the smooth muscle of the human urinary tract. Acta Pharmacol Toxicol 43: 111–118, 1978.CrossRefGoogle Scholar
  18. 18.
    Leval KU, Lutzeyer W: Spontaneous phasic activity of the detrusor: a cause of uninhibited contractions in unstable bladder. Urologia Int 35: 182–187, 1980.CrossRefGoogle Scholar
  19. 19.
    Andersson K-E, Fovaeus M, Morgan E, McLorie G: Comparative effects of five different calcium channel blockers on the atropine-resistant contraction in electrically stimulated rabbit urinary bladder. Neurourol Urodynam 5: 579–586, 1986.CrossRefGoogle Scholar
  20. 20.
    Peters D, et al.: Terodiline in the treatment of urinary frequency and motor urge incontinence. A controlled multicentre trial. Scand J Urol Nephrol (Suppl) 87: 21–33, 1984.Google Scholar
  21. 21.
    Castleden CM, George CF, Renwick AG, Asher MJ: Imipramine-a possible alternative to current therapy for urinary incontinence in the elderly. J Urol 125: 318–320, 1981.PubMedGoogle Scholar
  22. 22.
    Wein A, Malloy TR, Shofer F, Raezer DM: The effects of bethanechol chloride on urodynamic parameters in normal women and in women with significant residual urine volumes. J Urol 124: 397–399, 1980.PubMedGoogle Scholar
  23. 23.
    Light JK, Scott FB: Bethanechol chloride and the traumatic cord bladder. J Urol 128: 85–87, 1982.PubMedGoogle Scholar
  24. 24.
    Caine M, Raz S, Zeigler M: Adrenergic and cholinergic receptors in the human prostate, prostatic capsule and bladder neck. Br J Urol 47: 193–202, 1975.PubMedCrossRefGoogle Scholar
  25. 25.
    Ek A, Alm P, Andersson K-E, Person CG: Adrenergic and cholinergic nerves of human urethra and urinary bladder. A histochemical study. Acta Physiol Scand 99: 345–352, 1977.PubMedCrossRefGoogle Scholar
  26. 26.
    Hedlund H, Andersson K-E, Ek A: Effects of prazosin in patients with benign prostatic obstruction. J Urol 130: 275–278, 1983.PubMedGoogle Scholar
  27. 27.
    McConnell JD, Barry MJ, Bruskev RC, et al.: Benign Prostatic Hyperplasia: Diagnosis and Treatment. HCPR Publication No. 94-0582. Agency for Health Care Policy and Research, Public Health Service, U.S. Department of Health and Human Services, Rockville, MD, February 1994.Google Scholar
  28. 28.
    Isaccs JT, Coffey DT: Changes in DHT metabolism associated with the development of canine benign prostatic hyperplasia. Endocrinology 108: 445–453, 1981.CrossRefGoogle Scholar
  29. 29.
    Coffey DS: The endocrine control of normal and abnormal growth of the prostate. In: Urologie Endocrinology WB Saunders, Philadelphia, pp 170–193, 1986.Google Scholar
  30. 30.
    Ruffolo PR, Nichols AJ, Stadel JM, Hieble JP: Structure and function of alpha-adrenoreceptors. Pharmacological Rev 43: 475–505, 1991.Google Scholar
  31. 31.
    Lepor H, Tang R, Shapiro E: The alpha-adrenoceptor subtype mediating the tension in human prostatic smooth muscle. Prostate 22: 301–308, 1993.PubMedCrossRefGoogle Scholar
  32. 32.
    Gormley GJ, Stoner E, Bruskevitz RC, and the Finasteride Study Group: The effect of finasteride in men with benign prostatic hyperplasia. N Engl J Med 327: 1185–1191, 1992.CrossRefGoogle Scholar
  33. 33.
    Chapple CR, Stott M, Abrahms PH, Christmas TJ, Milroy EJG: A twelve week placebo-controlled study of prazosin in the treatment of prostatic obstruction due to benign prostatic hyperplasia. Br J Urol 70: 285–294, 1992.PubMedGoogle Scholar
  34. 34.
    Fawzy A, Sullivan J, Cook M, Gonzalez F: A multicentre sixteen week double blind, placebo-controlled dose response study using doxazosin for the treatment of BPH in patients with mild to moderate hypertension. J Urol 149: 323A, 1993.Google Scholar
  35. 35.
    Lapides JM, Diokno AC, Silber SJ, Lowe BS: Clean intermittent self-catheterization in the treatment of urinary tract disease. J Urol 107: 458–461, 1972.PubMedGoogle Scholar
  36. 36.
    Kass EJ, Koff SA, Diokno AC, Lapides J: The significance of bacilluria in children on long-term intermittent catheterization. J Urol 126: 223–225, 1981.PubMedGoogle Scholar

Copyright information

© Springer Science+Business Media New York 1998

Authors and Affiliations

  • J. Keith Light
    • 1
    • 2
  1. 1.Department of UrologyState University of New YorkUSA
  2. 2.Health Science CenterSyracuse College of MedicineSyracuseUSA

Personalised recommendations